© 2021 WLRN
MIAMI | SOUTH FLORIDA
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Television
Watch PBS » | About WLRN TV » | TV Schedules » | Producing for WLRN »About WLRN Public TelevisionWLRN-TV Channel 17 is a PBS (Public Broadcasting Service) member station licensed to the School Board of Miami-Dade County, Florida. During an average month, Channel 17 reaches over 600,000 TV households in the Miami - Ft. Lauderdale area with a viewing audience in four South Florida counties, from Palm Beach to Key West. WLRN is South Florida’s leading PBS Ready to Learn station airing thirteen hours of award-winning children’s programming daily. WLRN-TV also presents the best of the PBS nationally recognized series to compliment locally produced content. Our prime time schedule features an eclectic array of arts, performance, science, and WLRN original documentary specials to address the diverse interests of the South Florida community.Printable Monthly Schedules »WLRN Original DocumentariesProducing award winning original programs remains a high priority for WLRN. Take a closer look at some of the incredible stories that we have had the pleasure of producing for our South Florida viewers.Learn More »

The Business of Opioids

Frontline, Opioids Inc

10pm Friday FRONTLINE OPIOIDS INCInvestigative series - The story of a drug company that pushed opioids by bribing doctors and committing insurance fraud. With the Financial Times, FRONTLINE investigates how Insys Therapeutics profited from a fentanyl-based painkiller 50 times stronger than heroin.

The rise of pharmaceutical company Insys Therapeutics and the federal prosecution that brought it down following charges of bribing doctors to prescribe a highly addictive opioid painkiller.

What role have pharmaceutical companies played in fueling America’s epidemic of opioid addiction? How have they and their stockholders profited? And how are they being held accountable?

The new FRONTLINE documentary Opioids, Inc., part of a yearlong reporting collaboration with the Financial Times, explores those questions through the story of one company: Insys Therapeutics.

The documentary reveals how Insys bribed doctors, committed insurance fraud and made millions for Wall Street investors pushing a highly addictive opioid painkiller called Subsys — and then, how it became the first pharmaceutical company to have its CEO sentenced to prison time in connection with the opioid crisis.